All the information you need about PHARMACIE FLOURIOT to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-08-08 | Partially confidential | 2022-01-31 | Complete |
| 2019-11-26 | Partially confidential | 2019-01-31 | Complete |
| 2018-11-30 | Partially confidential | 2018-01-31 | Complete |
| 2017-07-25 | Partially confidential | 2017-01-31 | Complete |
| Name | PHARMACIE FLOURIOT |
| Siren | 538841354 |
| Closing | 2022-01-31 |
| Registry code | 2104 |
| Registration number | 7824 |
| Management number | 2012D00010 |
| Activity code | 4773Z |
| Closing date n-1 | 2021-01-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2022-08-08 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 21800 Neuilly-lès-Dijon |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AA Uncalled Subscribed Capital | 7.00 | |||
AB Establishment Expenses | 5.00 | |||
AF Concessions, Patents and Similar Rights | 290.00 | 290.00 | 290.00 | |
AH Goodwill | 961 632.00 | 961 632.00 | 961 632.00 | |
AR Technical installations, industrial equipment and tools | 14 398.00 | 10 891.00 | 3 507.00 | 14 398.00 |
AT Other tangible assets | 58 697.00 | 52 076.00 | 6 622.00 | 58 697.00 |
BH Other financial assets | 3 387.00 | 3 387.00 | 3 387.00 | |
BJ TOTAL (I) | 1 038 405.00 | 63 257.00 | 975 148.00 | 1 038 405.00 |
BT Goods | 175 323.00 | 175 323.00 | 175 323.00 | |
BX Customers and related accounts | 44 933.00 | 44 933.00 | 44 933.00 | |
BZ Other receivables | 22 719.00 | 22 719.00 | 22 719.00 | |
CD Marketable securities | 71 205.00 | 71 205.00 | 71 205.00 | |
CF Cash and cash equivalents | 199 477.00 | 199 477.00 | 199 477.00 | |
CH Prepaid expenses | ||||
CJ TOTAL (II) | 513 656.00 | 513 656.00 | 513 656.00 | |
CO Grand total (0 to V) | 1 552 061.00 | 63 257.00 | 1 488 804.00 | 1 552 061.00 |
CX Development or Research and Development Expenses | ||||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 100 000.00 | 40 290.00 | 100 000.00 | |
DD Legal reserve (1) | 4 029.00 | 4 029.00 | 4 029.00 | |
DH Retained earnings | 576 553.00 | 492 244.00 | 576 553.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 231 315.00 | 148 019.00 | 231 315.00 | |
DL TOTAL (I) | 911 897.00 | 684 582.00 | 911 897.00 | |
DU Loans and Debts from Credit Institutions (3) | 369 130.00 | 466 548.00 | 369 130.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 6 636.00 | 3 030.00 | 6 636.00 | |
DX Trade payables and related accounts | 107 508.00 | 117 706.00 | 107 508.00 | |
DY Tax and social security liabilities | 93 634.00 | 52 704.00 | 93 634.00 | |
EA Other liabilities | 910.00 | |||
EC TOTAL (IV) | 576 907.00 | 640 898.00 | 576 907.00 | |
EE Grand total (I to V) | 1 488 804.00 | 1 325 480.00 | 1 488 804.00 | |
